Pharaboz, Alexandre; Kimmoun, Antoine; Gunst, Jan; 60237; Duarte, Kevin; Merkling, Thomas; Gayat, Etienne; Mebazaa, Alexandre; Glenn-Chousterman, Benjamin;
PURPOSE: Factors associated with adverse outcomes in ICU patients with type II (T2DM) are poorly defined. The main goal of this study is to determine the impact of pre-existing T2DM on 90-day mortality post ICU admission. MATERIAL: Post-hoc analysis from the FROG-ICU cohort. All patients admitted to ICU who were ventilated and/or treated by a vasoa...
Van Loo, Magalie Iturriagagoitia Bassas, Xavier van Limmen, Jurgen Vandenheuvel, Michaël De Hert, Stefan
Lee, Anna De Waele, Jan Lipman, Jeffrey
Webbe, J Longford, N Battersby, C Ougham, K Uthaya, S Modi, N Gale, C
Objective To evaluate whether in preterm neonates parenteral nutrition use in the first seven postnatal days, compared with no parenteral nutrition use, is associated with differences in survival and other important morbidities. Randomised trials in critically ill older children show that harms, such as nosocomial infection, outweigh benefits of ea...
Van de Voorde, Patrick Turner, Nigel M. Djakow, Jana de Lucas, Nieves Martinez-Mejias, Abel Biarent, Dominique Bingham, Robert Brissaud, Olivier Hoffmann, Florian Johannesdottir, Groa Bjork
...
These European Resuscitation Council Paediatric Life Support (PLS) guidelines, are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations. This section provides guidelines on the management of critically ill infants and children, before, during and after cardiac arrest.
Raffaeli, Genny; Cavallaro, Giacomo; Allegaert, Karel; 46648; Koch, Birgit CP; Mosca, Fabio; Tibboel, Dick; Wildschut, Enno D;
Background: Bacterial and fungal infections are common and often contribute to death in patients undergoing extracorporeal membrane oxygenation (ECMO). Drug disposition is altered during ECMO, and adsorption in the circuit is an established causative factor. Vancomycin and voriconazole are widely used, despite the lack of evidence-based prescriptio...
Aziz, Shadman; Arabi, Yaseen M; Alhazzani, Waleed; Evans, Laura; Citerio, Giuseppe; Fischkoff, Katherine; Salluh, Jorge; Meyfroidt, Geert; 58374; Alshamsi, Fayez; Oczkowski, Simon;
...
Given the rapidly changing nature of COVID-19, clinicians and policy makers require urgent review and summary of the literature, and synthesis of evidence-based guidelines to inform practice. The WHO advocates for rapid reviews in these circumstances. The purpose of this rapid guideline is to provide recommendations on the organizational management...
Lakbar, Ines De Waele, Jan J Tabah, Alexis Einav, Sharon Martin-Loeches, Ignacio Leone, Marc
Published in
Advances in therapy
Antimicrobial de-escalation (ADE) is a component of antimicrobial stewardship (AMS) aimed to reduce exposure to broad-spectrum antimicrobials. In the intensive care unit, ADE is a strong recommendation that is moderately applied in clinical practice. Following a systematic review of the literature, we assessed the studies identified on the topic wh...
De Waele, Jan J. Schouten, Jeroen Beovic, Bojana Tabah, Alexis Leone, Marc
Published in
Intensive Care Medicine
Antimicrobial de-escalation (ADE) is defined as the discontinuation of one or more components of combination empirical therapy, and/or the change from a broad-spectrum to a narrower spectrum antimicrobial. It is most commonly recommended in the intensive care unit (ICU) patient who is treated with broad-spectrum antibiotics as a strategy to reduce ...
Dhaese, Sofie Van Vooren, Sarah Boelens, Jerina De Waele, Jan
Introduction Individualizing antibiotic therapy is paramount to improve clinical outcomes while minimizing the risk of toxicity and antimicrobial therapy. beta-lactam antibiotics are amongst the drugs most commonly prescribed in the Intensive Care Unit (ICU). The pharmacokinetics of beta-lactam antibiotics are profoundly altered in critically ill p...